⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 10, 2015Journal of Clinical Oncology

Anorexia Assessment in Patients With Cancer: A Crucial Issue to Improve the Outcome

Alessio Molfino Maurizio Muscaritoli Filippo Rossi Fanelli

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

no

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Molfino et al. (2015) studied this question.

synapsesocial.com/papers/6a881a6b729e8aa7bb5835a5 https://doi.org/10.1200/jco.2014.59.9548

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients With Advanced Cancer Using Opioids: A Randomized, Placebo-Controlled, Double-Blind TrialRCT · 2014 · 215 citations
2Contribution of anorexia to tissue wasting in cachexiaReview · 2010 · 39 citations
3Carnitine Administration Reduces Cytokine Levels, Improves Food Intake, and Ameliorates Body Composition in Tumor-Bearing RatsOriginal Research · 2011 · 27 citations
4The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratingsReview · 2000 · 674 citations
5Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4Journal of Clinical Oncology · 2026

KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non–Small Cell Lung CancerJournal of Clinical Oncology · 2026
Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 StudyJournal of Clinical Oncology · 2026
Art as a Shared Space: Tracing the Unseen Through a Body MapJournal of Clinical Oncology · 2026
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0Journal of Clinical Oncology · 2026
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 TrialJournal of Clinical Oncology · 2026

More from Journal of Clinical Oncology

More from Sapienza University of Rome